|Articles|June 15, 2003

BioPharm International

  • BioPharm International-06-01-2003
  • Volume 16
  • Issue 6

BioTrends: M&A Malaise

by Desiree de Myer, BioPharm International Despite market conditions favorable to merger and acquisition activity, a frenzy of consolidations still hasn't taken place.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.